Spots Global Cancer Trial Database for stereotactic body radiation therapy (sbrt)
Every month we try and update this database with for stereotactic body radiation therapy (sbrt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant | NCT03960008 | Hepatocellular ... HCC | Stereotactic Bo... Trans-Arterial ... Doxorubin | 18 Years - | Lahey Clinic | |
| Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer | NCT03137771 | Recurrent Non-S... Stage IV Non-Sm... | 3-Dimensional C... Docetaxel Gemcitabine Intensity-Modul... Pemetrexed Diso... Stereotactic Bo... Erlotinib Hydro... Pembrolizumab | 18 Years - | NRG Oncology | |
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma | NCT04921995 | Recurrent Nasop... Unresectable Na... Chemotherapy Ef... Immunotherapy Stereotactic Bo... | Tislelizumab | 15 Years - 90 Years | Fudan University | |
| Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging | NCT06276465 | Prostatic Cance... | Darolutamide 30... Stereotactic bo... Androgen depriv... | 18 Years - | UNICANCER | |
| Improving Pulmonary Function Following Radiation Therapy | NCT02843568 | Non-Small Cell ... | Laboratory Biom... Standard fracti... Stereotactic Bo... Four Dimensiona... | 18 Years - | University of Wisconsin, Madison | |
| A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer | NCT05169970 | Prostate Cancer | Stereotactic Bo... Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy | NCT05361798 | Cancer Of Prost... | M9241 Stereotactic Bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT05861557 | Locally Advance... | Toripalimab Stereotactic Bo... | 18 Years - | Tianjin Medical University General Hospital | |
| Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC | NCT02407171 | Melanoma Lung Cancer | MK-3475 Stereotactic Bo... | 18 Years - | Yale University | |
| Atezolizumab+Bevacizumab+SBRT in Unresectable HCC | NCT05096715 | Unresectable He... | Atezolizumab Bevacizumab Stereotactic bo... | 18 Years - | Massachusetts General Hospital | |
| SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | NCT03614949 | Cervical Cancer Cervical Cancer... Cervical Cancer... | Stereotactic bo... Atezolizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant | NCT03960008 | Hepatocellular ... HCC | Stereotactic Bo... Trans-Arterial ... Doxorubin | 18 Years - | Lahey Clinic | |
| Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma | NCT02782715 | Carcinoma, Rena... | Stereotactic Bo... Microwave Ablat... | 18 Years - | University of Wisconsin, Madison | |
| SRS Study in Patients With Non-Small Cell Lung Cancer | NCT00489008 | Lung Cancer | Stereotactic Bo... | - | M.D. Anderson Cancer Center | |
| Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma | NCT03168152 | Carcinoma, Hepa... | Microwave Ablat... Stereotactic Bo... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer | NCT03477864 | Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Ipilimumab Stereotactic Bo... Radical Prostat... Anti-PD-1 Monoc... | 18 Years - | Thomas Jefferson University | |
| Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery | NCT01766492 | Prostate Cancer Localized Malig... | Stereotactic Bo... | 18 Years - 99 Years | Georgetown University | |
| Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest Wall | NCT04507828 | Lung Cancer Metastatic Canc... | Treatment Plann... | 18 Years - | Indiana University | |
| Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest Wall | NCT04507828 | Lung Cancer Metastatic Canc... | Treatment Plann... | 18 Years - | Indiana University | |
| Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT02684253 | Head and Neck S... | Nivolumab Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma | NCT02989870 | HepatoCellular ... Unresectable He... Liver Cancer | Stereotactic Bo... Sorafenib Bavituximab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | NCT02206334 | Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta... | Stereotactic Bo... | 18 Years - | NRG Oncology | |
| Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | NCT01188486 | Lung Cancer Lung Cancer Non... Lung Cancer Sma... Mesothelioma | Stereotactic Bo... Computed Tomogr... Cyberknife Trilogy True Beam Iohexol Iodixanol | 18 Years - | Stanford University | |
| K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation | NCT06127940 | Non-small Cell ... | Stereotactic bo... Temporary Stopp... | 18 Years - | Karolinska University Hospital | |
| SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma | NCT01357525 | Adenocarcinoma ... | Stereotactic Bo... | 18 Years - 99 Years | University of Pittsburgh | |
| Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck | NCT02158234 | Squamous Cell C... | Cisplatin Stereotactic Bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer | NCT02254746 | Prostate Adenoc... | Stereotactic Bo... | 18 Years - 99 Years | Centre Hospitalier Universitaire Vaudois | |
| Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer | NCT01899989 | Non-small Cell ... | Stereotactic Bo... cisplatin or ca... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Liver Directed RT + Chemo-immunotherapy for ES-SCLC | NCT04923776 | Small-cell Lung... | Carboplatin Etoposide Atezolizumab Stereotactic Bo... | 18 Years - | Columbia University | |
| Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck | NCT02158234 | Squamous Cell C... | Cisplatin Stereotactic Bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer | NCT01899989 | Non-small Cell ... | Stereotactic Bo... cisplatin or ca... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases | NCT01792934 | Multi-organ Met... | XELOX regimen a... FOLFOX regimen ... Surgery radiofrequency ... transarterial c... stereotactic bo... Bevacizumab tumor biopsy | 18 Years - | Radboud University Medical Center | |
| Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone | NCT02880319 | Bone Cancer | Stereotactic Bo... Stereotactic Li... | 18 Years - | Dana-Farber Cancer Institute | |
| K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation | NCT06127940 | Non-small Cell ... | Stereotactic bo... Temporary Stopp... | 18 Years - | Karolinska University Hospital | |
| Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma | NCT03635164 | Squamous Cell C... | Durvalumab Stereotactic Bo... Standard of Car... | 18 Years - | University of Colorado, Denver | |
| SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma | NCT03546582 | Head and Neck S... | Pembrolizumab Stereotactic Bo... | 18 Years - | RTOG Foundation, Inc. | |
| Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer | NCT02572284 | Prostate Cancer | Stereotactic Bo... Prostatectomy Quality of Life... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Randomized Pilot Trial of Antimicrobial Therapy and Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Cancer | NCT03546829 | Early Stage Non... | Vancomycin Stereotactic Bo... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer | NCT03367702 | Stage II Prosta... | Intensity-Modul... Stereotactic Bo... | 18 Years - | NRG Oncology | |
| Single Fractions SBRT for Prostate Cancer | NCT04004312 | Prostate Cancer | Stereotactic Bo... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone | NCT02880319 | Bone Cancer | Stereotactic Bo... Stereotactic Li... | 18 Years - | Dana-Farber Cancer Institute | |
| Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer | NCT02572284 | Prostate Cancer | Stereotactic Bo... Prostatectomy Quality of Life... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer | NCT04130399 | Pancreatic Canc... Pancreatic Aden... | Stereotactic Bo... FOLFIRINOX | 18 Years - | Indiana University | |
| Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant | NCT03960008 | Hepatocellular ... HCC | Stereotactic Bo... Trans-Arterial ... Doxorubin | 18 Years - | Lahey Clinic | |
| Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC | NCT03965468 | Non-small Cell ... Stage IV Oligometastasis | Durvalumab Carboplatin Paclitaxel Stereotactic bo... Surgical resect... Radical radioth... Tremelimumab | 18 Years - | ETOP IBCSG Partners Foundation | |
| SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma | NCT01357525 | Adenocarcinoma ... | Stereotactic Bo... | 18 Years - 99 Years | University of Pittsburgh | |
| Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery | NCT04532177 | Breast Cancer | Stereotactic Bo... | 18 Years - | Stony Brook University | |
| PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients With LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) | NCT04854213 | Colorectal Canc... | Stereotactic Bo... | 18 Years - 80 Years | National Cancer Institute, Naples | |
| Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases | NCT03802747 | Colorectal Canc... | Durvalumab Durvalumab and ... Y-90 Selective ... Stereotactic Bo... | 18 Years - | University of Colorado, Denver | |
| A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer | NCT02254746 | Prostate Adenoc... | Stereotactic Bo... | 18 Years - 99 Years | Centre Hospitalier Universitaire Vaudois | |
| Stereotactic Body Radiation Therapy (SBRT) for Liver Mets | NCT01360606 | Liver Metastase... | Stereotactic Bo... | 18 Years - | University of Pittsburgh | |
| Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | NCT01434550 | Pancreatic Tumo... | Stereotactic Bo... Tissue, Blood, ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma | NCT04921995 | Recurrent Nasop... Unresectable Na... Chemotherapy Ef... Immunotherapy Stereotactic Bo... | Tislelizumab | 15 Years - 90 Years | Fudan University | |
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy | NCT03493789 | Stage I Lung Ca... Stage I Non-Sma... Stage IA Non-Sm... Stage IB Non-Sm... Stage II Lung C... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... | Fludeoxyglucose... Positron Emissi... Stereotactic Bo... | 18 Years - | Emory University | |
| Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer | NCT01899989 | Non-small Cell ... | Stereotactic Bo... cisplatin or ca... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors | NCT02239900 | Liver Cancer Lung Cancer | Ipilimumab Stereotactic Bo... | 18 Years - | M.D. Anderson Cancer Center | |
| T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy | NCT05361798 | Cancer Of Prost... | M9241 Stereotactic Bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma | NCT03071406 | Merkel Cell Car... Skin Cancer | Nivolumab Ipilimumab Stereotactic Bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma | NCT03635164 | Squamous Cell C... | Durvalumab Stereotactic Bo... Standard of Car... | 18 Years - | University of Colorado, Denver | |
| A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma | NCT01247298 | Hepatocellular ... | Stereotactic Bo... | 19 Years - | University of Alabama at Birmingham | |
| Pulmonary Interstitial Lymphography in Early Stage Lung Cancer | NCT01188486 | Lung Cancer Lung Cancer Non... Lung Cancer Sma... Mesothelioma | Stereotactic Bo... Computed Tomogr... Cyberknife Trilogy True Beam Iohexol Iodixanol | 18 Years - | Stanford University | |
| Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients | NCT05229575 | Stage IV Breast... | Stereotactic Bo... | 18 Years - | Campus Bio-Medico University | |
| Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma | NCT03071406 | Merkel Cell Car... Skin Cancer | Nivolumab Ipilimumab Stereotactic Bo... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma | NCT01360593 | Pancreatic Canc... | Gemcitabine Capecitabine Stereotactic Bo... | 18 Years - | University of Pittsburgh | |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | NCT02206334 | Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta... | Stereotactic Bo... | 18 Years - | NRG Oncology | |
| Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer | NCT04130399 | Pancreatic Canc... Pancreatic Aden... | Stereotactic Bo... FOLFIRINOX | 18 Years - | Indiana University | |
| Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) | NCT05038332 | Prostate Cancer | Ultra-hypofract... Moderately Hypo... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer | NCT02254746 | Prostate Adenoc... | Stereotactic Bo... | 18 Years - 99 Years | Centre Hospitalier Universitaire Vaudois | |
| A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer | NCT05169970 | Prostate Cancer | Stereotactic Bo... Stereotactic Bo... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer | NCT02206334 | Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta... | Stereotactic Bo... | 18 Years - | NRG Oncology | |
| SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN | NCT02057107 | Previously-Irra... Squamous Cell C... | SBRT Cetuximab Docetaxel | 18 Years - | University of Pittsburgh | |
| Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma | NCT01781728 | Pancreatic Canc... Periampullary A... | Stereotactic Bo... Stereotactic Bo... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery | NCT01766492 | Prostate Cancer Localized Malig... | Stereotactic Bo... | 18 Years - 99 Years | Georgetown University | |
| Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma | NCT02782715 | Carcinoma, Rena... | Stereotactic Bo... Microwave Ablat... | 18 Years - | University of Wisconsin, Madison | |
| Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies | NCT04235777 | Urothelial Canc... Bladder Cancer Genitourinary C... Urogenital Neop... Urogenital Canc... | M7824 M9241 Stereotactic bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | NCT01434550 | Pancreatic Tumo... | Stereotactic Bo... Tissue, Blood, ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy | NCT03493789 | Stage I Lung Ca... Stage I Non-Sma... Stage IA Non-Sm... Stage IB Non-Sm... Stage II Lung C... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... | Fludeoxyglucose... Positron Emissi... Stereotactic Bo... | 18 Years - | Emory University | |
| SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer | NCT06422156 | Advanced Pancre... | Stereotactic bo... Nimotuzumab mono-chemothera... | 18 Years - 75 Years | Peking University Third Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
